A Quote by John Paulson

There is a disconnect between the performance in stock market and the performance in many companies. — © John Paulson
There is a disconnect between the performance in stock market and the performance in many companies.
A stock market index helps investors track the performance of a group of stocks. NRDC worked with FTSE to develop comprehensive and transparent methodologies that screen out companies linked to owning, exploring, or extracting fossil fuels.
The relationship between executive CEO pay, stock performance is tenuous and not easily unscrambled, just one of myriad factors that affect the price of a stock.
Once you recognize that all documentaries are performance, it's not a matter of 'if' they should be performance. They are performance, and they are performance precisely where people are playing themselves.
It is much more difficult to measure non-performance than performance. Performance stands out like a ton of diamonds. Non-performance can almost always be explained away
My take is that acting is acting. A performance is a performance. With performance capture, if you don't get the performance on the day, you can't enhance the performance.
All good performance pieces have some philosophical validity. That's the difference between mere theater and performance art.
If we observe the performance of only those funds that remain active, we will tend to find that the average performance of the surviving funds exceeds that of the market.
The performance on the stage has its reasons in the performance induced in thousands of separate minds and this second performance is no less prodigious than the first.
No matter what you're doing, whether it's a makeup tutorial or an interview or a lip sync, performance is the essence of drag. It is gender performance. Being able to produce a performance is what a superstar has to do.
Unfortunately our stock is somehow not well understood by the markets. The market compares us with generic companies. We need to look at Biocon as a bellwether stock. A stock that is differentiated, a stock that is focused on R&D, and a very-very strong balance sheet with huge value drivers at the end of it.
Unfortunately, our stock is somehow not well understood by the markets. The market compares us with generic companies. We need to look at Biocon as a bellwether stock. A stock that is differentiated, a stock that is focused on R&D, and a very, very strong balance sheet with huge value drivers at the end of it.
When we deal in generalities, we shall never succeed. When we deal in specifics, we shall rarely have a failure. When performance is measured, performance improves. When performance is measured and reported, the rate of performance accelerates.
Men are enforced into a kind of silence about their gender; they're supposed to not think of it as a performance. That's the definition of manliness - that it's not a performance; it's being yourself, authentic. Whereas women have understood gender as performance. Men have not yet made that quantum leap, or rather they're making it in many ways, they're not thinking about it.
The stock market has gone up and if you are stock picking, that's fine, you may do a bit better than the market. But if you want to play in another game where you can get rapid increases of value and so on and so forth, this apparently has become the new parlour game, to invest in these companies and many their cases, the private equity that has been piling in onto of the venture capital is creating the unicorn, in other words the company with the $1 billion valuation.
You cannot judge the performance of an actor in isolation. A performance becomes good because of so many factors, including the other actors.
There is a complete disconnect really or should be a disconnect between the retail price of the milk and what's actually going on in the marketplace, and what influences the farm gate price is the export market.
This site uses cookies to ensure you get the best experience. More info...
Got it!